Cargando…

Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma

BACKGROUND: Asthma is a chronic respiratory condition, with airway hyperresponsiveness (AHR) and inflammation as hallmarks. The hypothesis that the substantially increased expression of arginase 1 in activated macrophages limits the availability of L-arginine for nitric oxide synthesis, and thus inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cloots, Roy H. E., Poynter, Matthew E., Terwindt, Els, Lamers, Wouter H., Köhler, S. Eleonore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967058/
https://www.ncbi.nlm.nih.gov/pubmed/29792217
http://dx.doi.org/10.1186/s12931-018-0809-9
_version_ 1783325557607366656
author Cloots, Roy H. E.
Poynter, Matthew E.
Terwindt, Els
Lamers, Wouter H.
Köhler, S. Eleonore
author_facet Cloots, Roy H. E.
Poynter, Matthew E.
Terwindt, Els
Lamers, Wouter H.
Köhler, S. Eleonore
author_sort Cloots, Roy H. E.
collection PubMed
description BACKGROUND: Asthma is a chronic respiratory condition, with airway hyperresponsiveness (AHR) and inflammation as hallmarks. The hypothesis that the substantially increased expression of arginase 1 in activated macrophages limits the availability of L-arginine for nitric oxide synthesis, and thus increases AHR in lungs of mice with experimentally induced allergic asthma was recently refuted by several studies. In the present study, we tested the hypothesis that, instead, a low circulating concentration of arginine aggravates AHR in the same murine asthma model. Female FVB F/A2(tg/tg) transgenic mice, which overexpress rat arginase 1 in their enterocytes, exhibit a ~ 50% decrease of their plasma L-arginine concentration. METHODS: Adult female F/A2(tg/tg) mice and their wild-type littermates (F/A2(wt/wt)) were sensitized and challenged with ovalbumin (OVA/OVA). Lung function was assessed with the flexiVent™ system. Adaptive changes in the expression of arginine-metabolizing or -transporting enzymes, chemokines and cytokines, and lung histology were quantified with qPCR, ELISA, and immunohistochemistry, respectively. RESULTS: Reduction of circulating L-arginine concentration significantly increased AHR in OVA/OVA-treated mice and, to a lesser extent, even in PBS/OVA-treated mice. The pulmonary inflammatory response in OVA/OVA-treated F/A2(tg/tg) and F/A2(wt/wt) mice was comparable. OVA/OVA-treated F/A2(tg/tg) mice differed from similarly treated female mice, in which arginase 1 expression in lung macrophages was eliminated, by a complete absence of an adaptive increase in the expression of arginine-metabolizing or –transporting enzymes. CONCLUSION: A reduction of the circulating L-arginine concentration rather than the macrophage-mediated increase of arginine catabolism worsens AHR. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0809-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5967058
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59670582018-05-24 Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma Cloots, Roy H. E. Poynter, Matthew E. Terwindt, Els Lamers, Wouter H. Köhler, S. Eleonore Respir Res Research BACKGROUND: Asthma is a chronic respiratory condition, with airway hyperresponsiveness (AHR) and inflammation as hallmarks. The hypothesis that the substantially increased expression of arginase 1 in activated macrophages limits the availability of L-arginine for nitric oxide synthesis, and thus increases AHR in lungs of mice with experimentally induced allergic asthma was recently refuted by several studies. In the present study, we tested the hypothesis that, instead, a low circulating concentration of arginine aggravates AHR in the same murine asthma model. Female FVB F/A2(tg/tg) transgenic mice, which overexpress rat arginase 1 in their enterocytes, exhibit a ~ 50% decrease of their plasma L-arginine concentration. METHODS: Adult female F/A2(tg/tg) mice and their wild-type littermates (F/A2(wt/wt)) were sensitized and challenged with ovalbumin (OVA/OVA). Lung function was assessed with the flexiVent™ system. Adaptive changes in the expression of arginine-metabolizing or -transporting enzymes, chemokines and cytokines, and lung histology were quantified with qPCR, ELISA, and immunohistochemistry, respectively. RESULTS: Reduction of circulating L-arginine concentration significantly increased AHR in OVA/OVA-treated mice and, to a lesser extent, even in PBS/OVA-treated mice. The pulmonary inflammatory response in OVA/OVA-treated F/A2(tg/tg) and F/A2(wt/wt) mice was comparable. OVA/OVA-treated F/A2(tg/tg) mice differed from similarly treated female mice, in which arginase 1 expression in lung macrophages was eliminated, by a complete absence of an adaptive increase in the expression of arginine-metabolizing or –transporting enzymes. CONCLUSION: A reduction of the circulating L-arginine concentration rather than the macrophage-mediated increase of arginine catabolism worsens AHR. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0809-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-23 2018 /pmc/articles/PMC5967058/ /pubmed/29792217 http://dx.doi.org/10.1186/s12931-018-0809-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Cloots, Roy H. E.
Poynter, Matthew E.
Terwindt, Els
Lamers, Wouter H.
Köhler, S. Eleonore
Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma
title Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma
title_full Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma
title_fullStr Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma
title_full_unstemmed Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma
title_short Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma
title_sort hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967058/
https://www.ncbi.nlm.nih.gov/pubmed/29792217
http://dx.doi.org/10.1186/s12931-018-0809-9
work_keys_str_mv AT clootsroyhe hypoargininemiaexacerbatesairwayhyperresponsivenessinamousemodelofasthma
AT poyntermatthewe hypoargininemiaexacerbatesairwayhyperresponsivenessinamousemodelofasthma
AT terwindtels hypoargininemiaexacerbatesairwayhyperresponsivenessinamousemodelofasthma
AT lamerswouterh hypoargininemiaexacerbatesairwayhyperresponsivenessinamousemodelofasthma
AT kohlerseleonore hypoargininemiaexacerbatesairwayhyperresponsivenessinamousemodelofasthma